Abstract:Background: Diabetes mellitus and pancreatic cancer are intimately related. Our previous studies showed that high levels of blood glucose promote epithelial-mesenchymal transition of pancreatic cancer. In this study, we evaluated the relationship between hyperglycemia and hypoxic tumor microenvironments. Methods: HIF-1 alpha expression was evaluated by immunohistochemistry in clinical pancreatic cancer tissues with or without diabetes mellitus. Statistcal analysis was performed to explore the relationship between HIF-1 alpha expression and pathological features of patients with pancreatic cancer. In vivo and in vitro models was established to detect whether a hyperglycemia environment could cause hypoxia in the pancreatic parenchyma and promote pancreatic cancer. In addition, we also tested the effect of HIF-1 alpha siRNA on the high glucose-induced invasive and migratory abilities of BxPC-3 cells in culture. Result: Our data showed that pancreatic cancer patients with diabetes had a higher level of HIF-1 alpha expression as well as biliary duct invasion and larger tumor volumes than individuals in the euglycemic group. Diabetic nude mice treated with streptozotocin (STZ) exhibited larger tumors and were more likely to develop liver metastasis than control mice. Acinar cells of the pancreas in diabetic mice showed an obvious expansion of the endoplasmic reticulum and increased nuclear gaps as well as chromatin close to the cellular membrane in some acinar cells. The expression area for Hypoxyprobe-1 and HIF-1 alpha in the diabetic orthotopic xenograft group was larger than that in the control group. The expression level of HIF-1 alpha in the BxPC-3 cancer cell line increased in response to high glucose and CoCl2 concentrations. The high glucose-induced invasive ability, migratory capacity and MMP-9 expression were counter-balanced by siRNA specific to HIF-1 alpha. Conclusion: Our results demonstrate that the association between hyperglycemia and poor prognosis can be attributed to microenvironment hypoxia in pancreatic cancer. (c) 2018 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

High Glucose Promotes Cell Proliferation and Enhances GDNF and RET Expression in Pancreatic Cancer Cells

High Glucose Promotes Pancreatic Cancer Cell Proliferation Via the Induction of EGF Expression and Transactivation of EGFR

High Glucose Microenvironment Accelerates Tumor Growth Via SREBP1-autophagy Axis in Pancreatic Cancer

High Glucose Promotes Pancreatic Cancer Cells to Escape from Immune Surveillance Via AMPK-Bmi1-GATA2-MICA/B Pathway

High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway

Hypoxia-inducible Factor-1α Mediates Hyperglycemia-induced Pancreatic Cancer Glycolysis.

HIF-1α mediates hyperglycemia-induced pancreatic cancer glycolysis.

High‑glucose Microenvironment Promotes Perineural Invasion of Pancreatic Cancer Via Activation of Hypoxia Inducible Factor 1Α.

Proliferation Enhanced By NGF-NTRK1 Signaling Makes Pancreatic Cancer Cells More Sensitive To 2DG-Induced Apoptosis

Hyperglycemia Enhances the Invasive and Migratory Activity of Pancreatic Cancer Cells Via Hydrogen Peroxide

High glucose promotes gastric cancer chemoresistance in vivo and in vitro.

Advanced Glycation End Products Increase Carbohydrate Responsive Element Binding Protein Expression and Promote Cancer Cell Proliferation

Hyperglycemia Aggravates Microenvironment Hypoxia and Promotes the Metastatic Ability of Pancreatic Cancer

EXPRESSION OF GLUCOSE TRANSPORTER-1 IN PANCREATIC CARCINOMA AND ITS CORRELATION WITH CELL PROLIFERATION AND APOPTOSIS

High Glucose-Upregulated PD-L1 Expression Through RAS Signaling-Driven Downregulation of PTRH1 Leads to Suppression of T Cell Cytotoxic Function in Tumor Environment

Hyperglycemia Promotes Pancreatic Cancer Initiation and Progression by Acti-vating the Wnt/beta-Catenin Signaling Pathway

Hydrogen Peroxide Mediates Hyperglycemia-Enhanced Invasive Ability of Pancreatic Cancer Cells Via Erk and P38 Mapk Pathways

High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway

Effect of P53 on Pancreatic Cancer-Glucose Tolerance Abnormalities by Regulating Transglutaminase 2 in Resistance to Glucose Metabolic Stress

Curcumin Attenuates Hyperglycemia-Driven EGF-induced Invasive and Migratory Abilities of Pancreatic Cancer Via Suppression of the ERK and AKT Pathways

Expression and Clinical Significance of Glucose Transporter-1 in Pancreatic Cancer.